London, June 25, 2026 – Elsevier has added StudyFinder AI to ClinicalKey Student to deliver trusted AI to medical education. 74% [1] of today’s medical students already use AI to support their studies, but many generic tools provide unverified answers lacking context, accuracy and transparency. Building on the launch of Osmosis AI earlier this year, the addition of StudyFinder AI allows students to use ClinicalKey Student to access trusted, evidence-based content quicker and more efficiently than ever before.
Addressing the growing demand for trusted AI in healthcare education, the enhanced ClinicalKey Student eliminates the risks often associated with generic AI alternatives. StudyFinder AI will initially be available in the UK, Australia and New Zealand, while Osmosis AI is currently available globally.
Brent Gordon, President of Elsevier Healthcare Education, said: “Most AI tools available to students today lack answers supported by trusted and verifiable sources. ClinicalKey Student is different − every StudyFinder AI response is drawn from content that medical schools recommend, including Elsevier’s evidence-based content, and is instantly verifiable. This is critical for students learning how to make clinical decisions.”
StudyFinder AI supports medical students in the following ways:
Nadya Affendy, a current UK medical student, said: “A key part of medicine is evidence-based learning which isn’t guaranteed by a lot of AI tools. That’s what stood out about StudyFinder; the AI bases itself off of trusted sources from Elsevier textbooks, as well as the NICE guidelines – the same kind of textbooks which are recommended by professors and lecturers throughout medical school.”
The announcement follows the launch of Osmosis AI in March this year, which provides the following capabilities:
Elsevier Healthcare Education also plans to launch its AI-powered Assessment Creator this summer in select markets as part of a new enterprise solution for medical education, saving faculty valuable time when creating curriculum-aligned, evidence-based assessments.
Find out more about ClinicalKey Student here .
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators across 170 countries in their vital work. We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world’s leading evidence-based scientific and medical content, precision AI, and expert human assessment. We champion inclusion and sustainability, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.
Elsevier is part of RELX , a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @elsevierconnect.
[1] Internal research study of 250 medical students (2025)